Lv4
440 积分 2025-01-07 加入
Risk of Enzyme- and Transporter-mediated Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2022: A Detailed Analysis of In Vitro and Clinical Data Available in New Drug Application Reviews
1天前
已完结
Clinical reliability and concordance of drug-drug interaction tools as clinical decision support systems in patients with epilepsy
2天前
已完结
Identification, reliability, and validity of drug–drug interaction checkers in chronic diseases: A systematic review
2天前
已完结
Next-generation experimental and computational strategies for drug-drug interaction prophecy
2天前
已完结
Computational approaches for drug–drug interaction prediction: a systematic review of data sources, modeling strategies, and evaluation frameworks
2天前
已完结
Advances and Challenges for Drug Interaction Evaluation - Perspectives on the ICH M12 Guideline
2天前
已完结
Assessing DDI risks in drug discovery and development: approaches, challenges, and trends
2天前
已完结
Reloxaliase in Enteric Hyperoxaluria — The Recent Brake
8天前
已完结
First-in-human phase I studies of YJ001 spray applied to local skin in healthy subjects and patients with diabetic neuropathic pain
23天前
已完结
A note on phase I interleaved versus parallel group ascending dose designs for concentration-QTc analyses
30天前
已完结
皖公网安备34019202002308
